Hillsborough, NJ, United States of America

Timothy A Gillespy

USPTO Granted Patents = 8 

 

Average Co-Inventor Count = 10.9

ph-index = 5

Forward Citations = 396(Granted Patents)


Location History:

  • Hillsboro, NJ (US) (2005 - 2012)
  • Hillsborough, NJ (US) (2009 - 2014)

Company Filing History:


Years Active: 2005-2014

Loading Chart...
Loading Chart...
8 patents (USPTO):Explore Patents

Title: Introducing Timothy A Gillespy: Prolific Inventor from Hillsborough, NJ

Introduction

Timothy A Gillespy is a distinguished inventor hailing from Hillsborough, NJ, with an impressive portfolio of 8 patents to his name. His innovative contributions have significantly impacted the field of pharmaceuticals, particularly in the realm of kinase inhibitors and benzimidazoles.

Latest Patents

Gillespy's latest patents showcase his expertise in the development of cutting-edge pharmaceutical compounds. One of his notable inventions includes a potent kinase inhibitor that demonstrates the ability to inhibit protein kinases effectively. Additionally, he has pioneered the creation of benzimidazoles, compounds known for their kinase-inhibiting properties.

Career Highlights

Throughout his career, Timothy A Gillespy has garnered experience working with reputable pharmaceutical companies such as Aventis Pharmaceuticals Inc. and Sanofi. His tenure at these organizations has been marked by a commitment to innovation and a relentless pursuit of groundbreaking solutions in the pharmaceutical industry.

Collaborations

Collaboration is key in the world of invention, and Gillespy has had the privilege of working alongside accomplished professionals such as Michael L Edwards and Charles J Gardner. Their collective expertise has undoubtedly contributed to the success of various projects and patents.

Conclusion

In conclusion, Timothy A Gillespy stands as a prominent figure in the realm of pharmaceutical innovations, with a track record of groundbreaking patents and collaborations. His dedication to pushing the boundaries of science and technology underscores his unwavering commitment to driving progress in the field.

This text is generated by artificial intelligence and may not be accurate.
Please report any incorrect information to support@idiyas.com
Loading…